James Gibson has resigned his position as Affymetrix’s VP and principal accounting officer. Gibson is leaving his post at Affy in order to pursue a senior financial management job at another company, Affy said in a filing with the US Securities and Exchange Commission.
Exosome Diagnostics has added three new members to its scientific advisory board: Dennis Brown, Xandra Breakefield, and Richard Edelson.